Nova Eye Medical Limited (ASX:EYE)

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005
Glaucoma Surgical Devices	23.16M
Glaucoma Surgical Devices Growth	38.99%
AlphaRET	168.00K
AlphaRET Growth	-53.85%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005
United States	17.31M
United States Growth	75.98%
Europe	3.94M
Europe Growth	-4.14%
Asia Pacific	1.77M
Asia Pacific Growth	-35.12%
Australia	27.00K
Australia Growth	-67.86%
Other	284.00K
Other Growth	3.65%